glp-1 agonists blindness risk π Optometrists are warning drugs may pose these types of rare risks π β¬οΈ Details in comments What Is Ozempic Blindness? Research
Description
Clarify any potential costs for medical records or administrative fees before signing
Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Combination With Semaglutide in Subjects Being Overweight or With Obesity (2020)
Leiter LA, Cefalu WT, de Bruin TW, et al
the half-life of Semaglutide is 57 days, so the drug should be ceased ~ 6 weeks before conception) [22, 34]
& Billiar, T
Therefore, the demand for GLP-1 drugs is increasing
